Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2018.6720
Abstract: Importance Multiple therapies are currently available for patients with neuroendocrine tumors (NETs), yet many therapies have not been compared head-to-head within randomized clinical trials (RCTs). Objective To assess the relative safety and efficacy of therapies… read more here.
Keywords: somatostatin analogue; network meta; analogue; plus somatostatin ... See more keywords
Somatostatin analogue scintigraphy in myocardial inflammation: An interesting image
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Nuclear Cardiology"
DOI: 10.1007/s12350-019-02023-0
Abstract: Endomyocardial biopsy may secure the diagnosis of myocarditis. Apart from its invasiveness, however, because of the patchy nature of the inflammatory infiltrates, it suffers in sensitivity. Cardiac magnetic resonance imaging is regarded a powerful noninvasive… read more here.
Keywords: inflammation interesting; somatostatin analogue; myocardial inflammation; scintigraphy myocardial ... See more keywords
Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Imaging"
DOI: 10.1186/s40644-018-0136-x
Abstract: BackgroundTo evaluate the effects of long-acting somatostatin analogue (SSA) therapy on 68Ga-DOTA-octreotate (GaTate) uptake at physiological and metastatic sites in neuroendocrine tumour (NET) patients.MethodsTwenty-one patients who underwent GaTate PET/CT before and after commencement of SSA… read more here.
Keywords: pet; long acting; ssa therapy; somatostatin analogue ... See more keywords